Prestige Must Shed Bonine To Win FTC Nod On $750M Deal

Prestige Must Shed Bonine To Win FTC Nod On $750M Deal

The Federal Trade Commission will require pharmaceutical company Prestige Brands Holdings Inc. to divest assets connected with the motion sickness drug Bonine to resolve competition concerns over its proposed $750 million acquisition of Insight Pharmaceuticals ...read more

  • Tags: